Home/Sporos Biodiscovery/Alex Cranberg, M.B.A.
AC

Alex Cranberg, M.B.A.

Board Member, Chairman & Founder of Aspect Energy

Sporos Biodiscovery

Therapeutic Areas

Sporos Biodiscovery Pipeline

DrugIndicationPhase
SPR1Cancers with Hippo-driver mutations/aberrations & YAP/TAZ hyperactivationIND Enabling
SPR2Cancers resistant to immunotherapyDiscovery in Vitro
SPR3Cancers resistant to MAPK inhibition and/or immunotherapyDiscovery in Vitro
SPR4PTEN-deficient cancersDiscovery in Vitro